Back to News
Market Impact: 0.5

2 Quantum Stocks to Avoid as 2026 Begins

RGTIWQBTSNFLXNVDANDAQ
Technology & InnovationCompany FundamentalsCorporate EarningsAnalyst EstimatesAnalyst InsightsInvestor Sentiment & PositioningMarket Technicals & Flows
2 Quantum Stocks to Avoid as 2026 Begins

Rigetti generated $5.2 million of revenue across the first three quarters of 2025, a 39% decline year-over-year, and booked two October 2025 system sales totaling $5.7 million that will not be recognized until H1 2026—creating a likely Q4 2025 revenue shortfall versus analyst expectations of $7.6 million and an EPS miss versus a projected $0.03 loss-per-share. D‑Wave posted under $22 million through the first three quarters of 2025 and likely finished the year below $26 million with no profit, yet trades at an approximately $9.7 billion market capitalization while analysts do not expect profitability before 2030. Both stories flag weak fundamentals and difficult near-term earnings visibility, supporting a cautious/avoid stance for these small-cap quantum names and a potential material negative re-rating if Q4 bookings and recognition timing disappoint.

Analysis

Market structure: Small-cap quantum hardware names (Rigetti RGTI, D‑Wave QBTS) are the clear losers as valuations (QBTS ≈ $9.7B vs <$26M revenue in 2025, ~300–400x revenue) are disconnected from fundamentals; winners are cloud incumbents (AWS, MSFT, GOOGL) and semiconductors (NVDA) that provide scalable quantum/AI compute and can monetize real demand. The supply/demand picture shows strong headline demand/bookings but lumpy revenue recognition: two Rigetti system sales announced Oct 2025 likely push revenue into H1 2026, creating a one-time timing shock rather than underlying growth. Cross‑asset: a tech unwind would push Treasury yields down (flight to safety), VIX up 30–70% near-term, USD slight bid; commodities unaffected materially. Risk assessment: Immediate tail risk is an earnings miss at Rigetti in early March 2026 (analyst revenue consensus $7.6M) that could trigger a 30–60% repricing; short‑term (weeks–months) risks include dilution from convertible raises and a failed revenue recognition audit; long‑term risk for QBTS is inability to reach profitability before 2030 as consensus implies. Hidden dependencies include revenue recognition policy, customer acceptance/installation timelines, and small float-induced volatility; catalysts that can reverse trends include H1 2026 booking recognition, large cloud partnership announcements, or faster-than-expected margin improvement. Trade implications: Tactical short bias: size constrained shorts in RGTI/QBTS ahead of Rigetti’s March 2026 Q4 print and D‑Wave’s next quarter, funded by longs in NVDA or SOXX to capture secular AI/compute rotation. Options: prefer limited‑cost structures—buy 12–16 week ATM put or 3–6 month 30/15 delta put spreads on RGTI/QBTS to limit premium and manage gamma. Allocate macro hedge (0.5% portfolio) to VIX futures or 1‑month SPX puts into earnings season; rotate proceeds into semis/cloud if market dislocations widen. Contrarian angles: Consensus underestimates the timing benefit of the two Rigetti system sales—if H1 2026 bookings translate to multi‑year service/maintenance ARR, downside could be less than priced in; conversely, reaction may be overdone if shorts ignore the tiny float and potential for squeezes. Historical parallels: hardware hype cycles (cleantech, 2010s semicap microcaps) show fast blowups then 60–90% collapses on execution misses, arguing for option‑defined risk trades rather than naked shorts. Monitor insider activity, 8‑K revenue recognition notes, and analyst revisions within 7–14 days of earnings for de‑risk triggers.